<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>molecular imaging &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/molecular-imaging/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 24 Oct 2025 16:20:09 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>molecular imaging &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>October 24, 2025: Journal of Nuclear Medicine Ahead-of-Print Highlights</title>
		<link>https://bioengineer.org/october-24-2025-journal-of-nuclear-medicine-ahead-of-print-highlights/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 24 Oct 2025 16:20:05 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[amyloid plaque quantification]]></category>
		<category><![CDATA[cytokine imaging]]></category>
		<category><![CDATA[molecular imaging]]></category>
		<category><![CDATA[novel PET tracer ¹⁸F-MeFAMP]]></category>
		<category><![CDATA[theranostics in oncology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/october-24-2025-journal-of-nuclear-medicine-ahead-of-print-highlights/</guid>

					<description><![CDATA[Reston, VA (October 24, 2025) — Pioneering advancements in nuclear medicine have taken a significant leap forward with a collection of newly released studies published ahead-of-print in The Journal of Nuclear Medicine (JNM), a leading scientific periodical in the field. These latest investigations delve deep into molecular imaging and theranostics, illuminating innovative diagnostic and therapeutic [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">286420</post-id>	</item>
		<item>
		<title>Ahead-of-Print Highlights from The Journal of Nuclear Medicine – April 18, 2025</title>
		<link>https://bioengineer.org/ahead-of-print-highlights-from-the-journal-of-nuclear-medicine-april-18-2025/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 18 Apr 2025 14:37:25 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[CAR T therapy monitoring]]></category>
		<category><![CDATA[molecular imaging]]></category>
		<category><![CDATA[neurodegenerative diagnostics]]></category>
		<category><![CDATA[PET radiotracers]]></category>
		<category><![CDATA[precision oncology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/ahead-of-print-highlights-from-the-journal-of-nuclear-medicine-april-18-2025/</guid>

					<description><![CDATA[Reston, VA (April 18, 2025)—In a series of breakthrough developments, The Journal of Nuclear Medicine (JNM) has unveiled pioneering research that promises to revolutionize diagnostic imaging and precision medicine in oncology and neurology. These newly published studies leverage cutting-edge molecular imaging technologies to enhance the detection, differentiation, and prognosis of complex diseases, representing significant strides [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">241506</post-id>	</item>
	</channel>
</rss>
